Loren Data Corp.

'

 
 

COMMERCE BUSINESS DAILY ISSUE OF FEBRUARY 26,1999 PSA#2291

National Cancer Institute, Research Contracts Branch, PCPSS, 6120 Executive Blvd, Room 635, Bethesda, MD 20892-7226

A -- PROSTATE, LUNG, COLO-RECTAL AND OVARIAN (PLCO) CANCER SCREENING TRIAL SOL See Description POC Susan K. Hoffman, Contracting Officer, 301-435-3799 E-MAIL: Susan K. Hoffman, sh191h@nih.gov. The National Cancer Institute intends to negotiate with the following Screening Centers of the Prostate, Lung, and Ovarian (PLCO) Cancer Screening Trial for implementation of the following Protocol Modifications (1.) Add CA125 and PSA tests in years T4 and T5; (2.) Add biorepository collections in T4 and T5; and (3.) Follow-up extended for three (3) years, through 2011. The Screening Center Contracts are as follows: University of Alabama -- N01-CN-75022, Georgetown University -- N01-CN-25522, Henry Ford Hospital -- N01-CN-25512, Marshfield Medical Research and Education Foundation -- N01-CN-25518, Straub Pacific Health Foundation -- N01-CN-25515, University of Colorado, N01-CN-25514, University of Minnesota, N01-CN-25513, University of Pittsburgh -- N01-CN-25511, University of Utah -- N01-CN-25524, Washington University -- N01-CN-25516. Authority: 41 U.S.C. 253(c)(1), as set forth in FAR 6.302-1. Inherent duplication of cost to the government and privacy rights of PLCO participants make competition unfeasible. See Numbered Note 22. Posted 02/24/99 (W-SN301701). (0055)

Loren Data Corp. http://www.ld.com (SYN# 0005 19990226\A-0005.SOL)


A - Research and Development Index Page